Subsets of activated T cells in patients with systemic lupus erythematosus: The relation to cell cycle

Scandinavian Journal of Rheumatology

Volumn 26, Issue 1, 1997, Pages 37-42

  Tokano, Y ^a   Morimoto, S ^a   Hishikawa, T ^a   Murashima, A ^a   Abe, M ^a   Sekigawa, I ^a   Takasaki Y ^a   Hashimoto, H ^a   Okumura, K ^a   Shirai, T ^a   Hirose, S ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

cell cycle; HLA DP+ T cells; PCNA+ lymphocytes; soluble IL 2R; systemic lupus erythematosus

Indexed keywords

HLA DP ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ADULT; ARTICLE; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 8044245470     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749709065662     Document Type: Article

References (27)

1. Jasin HE, Ziff M. Immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus. Arthritis Rheum 1992; 18: 219-28.
2. Budman DR, Merchant EB, Steinberg AD, Doft B, Gershwin ME, Lizzio E, et al. Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE. Arthritis Rheum 1975; 20: 829-33.
3. Blaese RM, Grayson J, Steiberg AD. Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus. Am J Med 1980; 69: 345-50.
4. Linker-Israeli M, Bakke AC, Kitridou RC, Gendler S, Gillis S, Honvitz DA. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol 1983; 130: 2651-5.
5. Linker-Israeli M, Bakke AC, Quismorio FP Jr, Honvitz DA. Correlation of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells. J Clin Invest 1985; 75: 762-8.
6. Miyasaka N, Nakamura T, Rüssel U, Talal N. Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol 1984; 31: 109-17.
7. Murakawa Y, Takada S, Ueda Y, Suzuki N, Hoshino T, Sakane T. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus. J Immunol 1985; 134: 187-94.
8. Huang Y-P, Perrin LH, Miescher PA. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. J Immunol 1988; 141: 827-33.
9. Klashman DJ, Martin RA, Martinez-Maza O, Stevens RH. In vitro regulation of B cell differentiation by interleukin-6 and soluble CD23 in systemic lupus erythematosus B cell subpopulations and antigen-induced normal B cells. Arthritis Rheum 1991; 34: 276-86.
10. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, OzeriChen T, Klinenberg JR. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. J Immunol 1991; 147:117-23.
11. Smolen JS, Chused TM, Leiserson WM, Reeves JP, Ailing D, Steinberg AD. Heterogeneity of immunoregulatory T-cell subsets in systemic lupus erythematosus. Am J Med 1982; 72: 783-90.
12. Wolf RE, Breisford WG. Soluble interleukin-2 receptors in systemic lupus erythematosus. Arthritis Rheum 1988; 31: 729-35.
13. Tokano Y, Murashima A, Takasaki Y, Hashimoto H, Okumura K. Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus. Ann Rheum Dis 1989; 48: 803-9.
14. Yu DTY, Winchester RJ, Fu SM, Gibofsky A, Ko HS, Kunkel HG. Peripheral blood la-positive T cells. Increases in certain diseases and after immunization. J Exp Med 1980; 151:91-100.
15. Hirano T, Taniguchi O, Koga K, Hashimoto H, Hirose S, Shiokawa Y, et al. The appearance of Ia+ T cell in systemic lupus erythematosus. In: Kano K, Mori S, Sugisaki T, et al., eds. Cellular, molecular and genetic approaches to immunodiagnosis and immunotherapy. Tokyo; University of Tokyo Press, 1987: 441-5.
16. Tokano Y, Hishikawa T, Hirose T, Sekigawa I, Hashimoto H, Okumura K, et al. HLA-DP-positive T cells in patients with systemic lupus erythematosus. Autoimmunity 1990; 5: 179-83.
17. Murashima A, Takasaki Y, Ohgaki M, Hashimoto H, Shirai T, Hirose S. Activated peripheral blood mononuclear cells detected by murine monoclonal antibodies to proliferating cell nuclear antigen in active lupus patients. J Clin Immunol 1990; 10: 28-37.
18. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
19. Liang WH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107-18.
20. Bacon PA, Coppock JS, Isenberg DA, Maddison PH, Snaith ML, Symmons DPM, et al. A comparison of disease activity scores in SLE (abstract). Br J Rheumatol 1986; 15: 16A.
21. Lampson LA, Levy R. Two populations of la-like molecules on a human B cell line. J Immunol 1980; 125: 293-9.
22. Watson AJ, DeMars R, Trowbridge IS, Bach FH. Detection of a novel human class II HLA antigen. Nature 1983; 304: 358-61.
23. Hishikawa T, Tokano Y, Sekigawa I, Ando S, Takasaki Y, Hashimoto H, et al. HLA-DP+ T cells and deficient interleukin-2 production in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1990; 55: 285-96.
24. Traganos F, Darzykiewicz Z, Sharpless T, Melamed MR. Simultaneous staining of ribonucleic and deoxyribonucleic acids in unfixed cells using acridine orange in a flow cytofluorometric system. J Histochem Cytochem 1977; 25: 46-56.
25. Ueda G, Hirose S, Shirai T. An early activation antigen of murine T cells recognized by monoclonal natural autoantibody NTA204 and the expression on T cells from aged NZBXNZW Fl mice with overt autoimmune disease. Autoimmunity 1992; 12: 117-25.
26. Pledger WJ, Stiles CD, Antoniades HN, Scher CD. An ordered sequence of events is required before BALB/C-3T3 cells become committed to DNA synthesis. Proc Natl Acad Sci USA 1978; 75: 2839-43.
27. Stiles CD, Capone GT, Scher CD, Antoniades HN, Van Wyk JJ, Pledger WJ. Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci USA 1979; 78: 1279-83.